Tobacco News and Research

RSS

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.

28 Jul 2014

New York City moves forward to implement law banning tobacco discounting schemes

Tobacco companies have abandoned their legal challenge to New York City's innovative new law prohibiting tobacco discounting schemes, as they chose not to appeal a federal court ruling that upheld the law. The deadline for the tobacco companies to appeal was July 18.

26 Jul 2014

Mexico, US sign statement of intent to promote safety of fresh agricultural products

The U.S. Food and Drug Administration and the government of Mexico's National Service for Agro-Alimentary Public Health, Safety and Quality (SENASICA) and Federal Commission for the Protection from Sanitary Risks (COFEPRIS) signed a statement of intent forming a partnership to promote the safety of fresh and minimally processed agricultural products.

25 Jul 2014

Direct medical costs projected to increase to $49 billion annually by 2020

The American College of Chest Physicians announced today the Online First publication of 'Total and State-Specific Medical and Absenteeism Costs of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years in the United States for 2010 and Projections Through 2020' in the journal CHEST.

25 Jul 2014

Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

A new Mayo Clinic study, published online today by the journal Menopause, found an association between caffeine intake and more bothersome hot flashes and night sweats in postmenopausal women.

24 Jul 2014

FDA approves Targiniq ER to treat severe pain

Today, the U.S. Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), an extended-release/long-acting (ER/LA) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

24 Jul 2014

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood cancers.

24 Jul 2014

Highlights: Florida officials crack down on direct Medicaid marketing; a wellness plan in Washington state breaks the mold

[Florida] health officials are taking a cue from past problems and are banning health insurance companies from marketing their plans directly to Medicaid consumers as the state is rolling out a massive overhaul by transitioning millions into managed care. Insurance companies are allowed to market to consumers under the contracts, but only if the state gives prior approval (Kennedy, 7/22).

23 Jul 2014

First Edition: July 22, 2014

Reporting for Kaiser Health News, Susan Jaffe writes: "Medicare officials have allowed patients at dozens of hospitals participating in pilot projects across the country to be exempted from the controversial requirement that limits nursing home coverage to seniors admitted to a hospital for at least three days.

22 Jul 2014

BP variability may be ‘CV risk integrator’

Increased variability in blood pressure may be an indicator of overall cardiovascular risk rather than being a risk factor per se, suggest researchers.

21 Jul 2014

First Edition: July, 21, 2014

Today's headlines include a story about an effort by regulators to widen insurer networks, as well as a range of other health policy developments.

21 Jul 2014

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

The U.S. Food and Drug Administration yesterday approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema (HAE).

18 Jul 2014

Oral Cancer and Cody Kiser partner at upcoming Snake River Stampede Rodeo

While the world of rodeo has been the realm of sponsorship by the tobacco industry for decades, The Oral Cancer Foundation today takes a stand and introduces their new spokesperson, Cody Kiser; a rodeo cowboy who will be debuting his partnership with the foundation at the upcoming Snake River Stampede Rodeo in Nampa, ID.

16 Jul 2014

Research highlights potential cancer risk in non-smokers

Research led by the University of York has highlighted the potential cancer risk in non-smokers - particularly young children - of tobacco smoke gases and particles deposited to surfaces and dust in the home.

16 Jul 2014

Smoking may increase suicide risk

Cigarette smokers are more likely to commit suicide than people who don't smoke, studies have shown. This reality has been attributed to the fact that people with psychiatric disorders, who have higher suicide rates, also tend to smoke.

16 Jul 2014

UN Member States reaffirm commitment to reduce avoidable burden of NCDs

UN Member States have reaffirmed their commitment to take bold measures to reduce the avoidable burden of noncommunicable diseases (NCDs). These ailments, including heart disease and stroke, cancer, diabetes and lung disease kill 38 million people every year, many of them before they reach the age of 70.

13 Jul 2014

Charles H. Hennekens wins prestigious Alton Ochnser Award

The Ochnser Clinic Foundation recently announced that the 29th annual recipient of the prestigious Alton Ochnser Award is Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University.

11 Jul 2014

WHO report provides updated overview of NCD situation

As world leaders gather at the United Nations General Assembly to assess efforts made since 2011 in controlling noncommunicable diseases (NCDs) like heart disease, cancer, diabetes and chronic lung disease, the new WHO "Noncommunicable diseases country profiles 2014" show progress has been insufficient and uneven.

11 Jul 2014

90.7% of non-cannabis users meet criteria for problematic drug use, shows study

Of emergency patients who reported any drug other than marijuana as their primary drug of use, 90.7 percent met the criteria for problematic drug use.

10 Jul 2014

New knowledge may expand treatments for patients with lung cancer

Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.

10 Jul 2014

Tobacco News and Research

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

New York City moves forward to implement law banning tobacco discounting schemes

Mexico, US sign statement of intent to promote safety of fresh agricultural products

Direct medical costs projected to increase to $49 billion annually by 2020

Caffeine intake may aggravate hot flashes and night sweats in postmenopausal women

FDA approves Targiniq ER to treat severe pain

Zydelig gets FDA approval for treatment of patients with three types of blood cancers

Highlights: Florida officials crack down on direct Medicaid marketing; a wellness plan in Washington state breaks the mold

First Edition: July 22, 2014

BP variability may be ‘CV risk integrator’

First Edition: July, 21, 2014

FDA approves Ruconest for treatment of acute attacks in adolescent patients with HAE

Oral Cancer and Cody Kiser partner at upcoming Snake River Stampede Rodeo

Research highlights potential cancer risk in non-smokers

Smoking may increase suicide risk

UN Member States reaffirm commitment to reduce avoidable burden of NCDs

Charles H. Hennekens wins prestigious Alton Ochnser Award

WHO report provides updated overview of NCD situation

90.7% of non-cannabis users meet criteria for problematic drug use, shows study

New knowledge may expand treatments for patients with lung cancer

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News